Background and governance
In 2013, Novo Nordisk and the University of Oxford established a prestigious international fellowship programme. Novo Nordisk has provided a total of £9.3m of funding to support a total of 32 research fellows based at the University of Oxford, each for a 3 year period, between 2014 and 2023. The aim of the fellowship programme is to support the development of a new generation of exceptional young diabetes researchers, who will become future leaders in the field.
The research included in the fellowship programme focuses on diabetes and metabolism and spans the translational spectrum, from basic research through to clinical application. Approaches taken include basic mechanistic understanding at the cellular level, systems biology, big data integrative approaches, in vivo physiology and clinical studies.
The fellowship programme is coordinated by the Radcliffe Department of Medicine but encompasses all researchers in Oxford with a focus in diabetes and metabolism.
The programme’s success is underpinned by a Joint Steering Committee, which is led by Professor Hugh Watkins and has representatives from both partners. This committee is supported by Dr Serena Briant, who manages the fellowship programme at the University of Oxford and is supported by Dr Kathleen Dolan, and Dr Dorthe Lundsgaard who manages the fellowship programme at Novo Nordisk.